Stockreport

Stifel starts AnaptysBio at buy, cites upcoming catalysts [Seeking Alpha]

AnaptysBio, Inc.  (ANAB) 
Last anaptysbio, inc. earnings: 3/2 08:45 am Check Earnings Report
US:NASDAQ Investor Relations: ir.anaptysbio.com/investor-relations
PDF Stifel said its bullish rating is based on its belief that immune cell modulation “represents a key part of the evolution in the treatment paradigm of autoimmune diseas [Read more]